Compare · CAH vs COR
CAH vs COR
Side-by-side comparison of Cardinal Health Inc. (CAH) and Cencora Inc. (COR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAH and COR operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR is the larger of the two at $59.91B, about 1.1x CAH ($53.52B).
- Over the past year, CAH is up 43.3% and COR is up 5.2% - CAH leads by 38.1 points.
- COR has been more active in the news (7 items in the past 4 weeks vs 4 for CAH).
- Both have 25 recent analyst ratings on file.
- Company
- Cardinal Health Inc.
- Cencora Inc.
- Price
- $228.56-0.07%
- $307.84-0.03%
- Market cap
- $53.52B
- $59.91B
- 1M return
- +0.34%
- +9.52%
- 1Y return
- +43.26%
- +5.19%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 4
- 7
- Recent ratings
- 25
- 25
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Latest CAH
- Cardiovascular Logistics Names Dr. Gary Kirsh Chief Executive Officer
- Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11
- SEC Form 11-K filed by Cardinal Health Inc.
- SEC Form 11-K filed by Cardinal Health Inc.
- SEC Form SD filed by Cardinal Health Inc.
- Cardinal Health Board of Directors Approves Quarterly Dividend
- SEC Form 10-Q filed by Cardinal Health Inc.
- Cardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook
- William Blair initiated coverage on Cardinal Health
Latest COR
- Executive Vice President Battaglia Silvana was granted 58 shares, increasing direct ownership by 0.25% to 23,624 units (SEC Form 4)
- Executive Vice President Campbell Elizabeth S was granted 50 shares, increasing direct ownership by 0.16% to 30,756 units (SEC Form 4)
- Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
- SEC Form 4 filed by Chief Financial Officer Boratto Eva C
- New insider Boratto Eva C claimed ownership of 3 shares (SEC Form 3)
- Director Tyler Lauren M bought $148,626 worth of shares (550 units at $270.23), increasing direct ownership by 14% to 4,359 units (SEC Form 4)
- Director Durcan Dermot Mark bought $1,096,760 worth of shares (4,000 units at $274.19), increasing direct ownership by 14% to 31,767 units (SEC Form 4)
- SEC Form 11-K filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Announces Samantha Hammock as Chief Human Resources Officer